At a glance
- Originator Egis Pharmaceuticals; Servier
- Developer Egis Pharmaceuticals
- Class Benzodiazepines
- Mechanism of Action AMPA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Neurological disorders
Most Recent Events
- 15 Dec 2003 No development reported - Preclinical for Neurological disorders (Prevention) in Hungary (unspecified route)
- 25 Aug 2000 New profile
- 25 Aug 2000 Preclinical development for Neurological disorders (Prevention) in Hungary (Unknown route)